Classification
- Anatomical main groupMMusculo-skeletal system
- Therapeutic subgroupM09
- Pharmacological subgroupM09A
- Chemical subgroupM09AXOther drugs for disorders of the musculo-skel syst
- Chemical substanceM09AX10Risdiplam
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Canada
Health Canada · 2 registrations
Spain
AEMPS · 2 registrations
Netherlands
CBG-MEB · 2 registrations
At a glance
- ATC code
- M09AX10
- ATC group
- Musculo-skeletal system
- Registers
- 10
- Historical lists
- 1
- Registrations
- 16
- With their own page
- 15
- Companies
- 7
All medicines with Risdiplam
Human medicines from every register that match Risdiplam by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
16 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Evrysdi | United States | 5MG | tablet | Marketed | Genentech INC |
| Evrysdi | United States | 0.75MG/ML | for solution | Marketed | Genentech INC |
| Evrysdi | European Union | Authorised | Roche Registration GmbH | ||
| Evrysdi 5 MG Comprimidos Recubiertos con Pelicula | Spain | 5 mg | comprimido recubierto con película | Marketed | Roche Registration Gmbh |
| EVRYSDI 0,75 mg/ml POLVO PARA SOLUCION ORAL | Spain | 0,75 mg | polvo para solución oral | Marketed | Roche Registration Gmbh |
| Evrysdi 5 mg filmomhulde tabletten | Netherlands | Filmomhulde tablet | Authorised | Roche Registration GmbH | |
| Evrysdi, 0,75mg/ml, poeder voor oraal gebruik | Netherlands | Poeder voor oraal gebruik | Authorised | Roche Registration GmbH | |
| Evrysdi® | Serbia | 0.75mg/mL | prašak za oralni rastvor | Authorised | Roche DOO Beograd |
| Evrysdi | Canada | 5 MG | Tablet | Marketed | Hoffmann-LA Roche Limited |
| Evrysdi | Canada | 0.75 MG / ML | Powder For Solution | Marketed | Hoffmann-LA Roche Limited |
| Evrysdi | Brazil | Authorised | Produtos Roche Químicos e Farmacêuticos S.A. | ||
| Evrysdi Film-Coated Tablet 5MG | Singapore | 5.000 mg | tablet, film coated | Authorised | Roche Singapore Pte. LTD. |
| Evrysdi Powder for Oral Solution 0.75 MG/ML | Singapore | 60 mg | powder, for solution | Authorised | Roche Singapore Pte. LTD. |
| Evrysdi | Croatia | Marketed | |||
| Evrysdi | New Zealand | Powder for oral soln 750 mcg per ml, 60 mg per bottle | Funded | ||
| Evrysdi 60 mg/80ml | Saudi Arabia | Authorised | F. Hoffmann-La Roche Ltd. |